Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
തുറക്കുക
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
—1,093.811,096.521,100.221,091.51——
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
—1,761.111,764.271,766.881,744.71——
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
—642.58644.87648.48640.18——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
—3,211.833,227.213,268.383,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
—1,474.521,479.031,481.041,466.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
—2,392.122,396.952,421.222,382.32——
BRM:ETR
Bristol-Myers Squibb Co
€51.45
+3.61%
(+1.80) 1D
ഏപ്രി 30, ജിഎംടി+2 5:35:44 PM  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BRM...
തുറക്കുക
€48.44
High
€51.53
Low
€48.44
Mkt. cap
൧൧൮.൮൭B
Avg. vol.
൧.൩൧K
Volume
൧.൩൬K
52-wk high
€54.02
52-wk low
€36.60
No. of employees
൩൨K
News stories
From sources across the web
Simply Wall Street
Simply Wall Street
·
4 മണിക്കൂർ മുമ്പ്
A Look At Bristol Myers Squibb (BMY) Valuation After Its Q1 2026 Earnings Beat And Reaffirmed Guidance
MarketBeat
MarketBeat
·
6 മണിക്കൂർ മുമ്പ്
Mcdonald Partners LLC Grows Holdings in Bristol Myers Squibb Company $BMY
Seeking Alpha
Seeking Alpha
·
2 ദിവസം മുമ്പ്
Bristol-Myers Squibb Company 2026 Q1 - Results - Earnings Call Presentation (NYSE:BMY) 2026-04-30
TipRanks
TipRanks
·
2 ദിവസം മുമ്പ്
Why Bristol-Myers Squibb Stock Is Sinking Now
പ്രൊഫൈൽ
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2024, 71% of the company's revenues came from the United States. The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
About Bristol-Myers Squibb Co
CEOക്രിസ് ബോർനർ
Employees32.5K
Founded1887
Headquartersന്യൂ യോർക്ക്, ന്യൂയോർക്ക്, അമേരിക്ക
Sector-
Websitebms.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 ജൂൺ
2025 സെപ്റ്റം
2025 ഡിസം
2026 മാർ
Revenue
12.27B
12.22B
12.50B
11.49B
Cost of goods sold
3.36B
3.31B
3.51B
3.42B
Cost of revenue
3.36B
3.31B
3.51B
3.42B
Research and development expenses
2.26B
2.43B
2.56B
2.65B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.69B
1.79B
2.09B
1.62B
Operating expense
4.78B
5.05B
5.47B
4.70B
Total operating expenses
8.14B
8.36B
8.98B
8.12B
Operating income
4.13B
3.86B
3.52B
3.36B
Other non operating income
399.00M
529.00M
544.00M
-32.00M
EBT including unusual items
1.77B
3.11B
1.47B
3.24B
EBT excluding unusual items
4.22B
4.07B
3.86B
3.33B
Income tax expense
460.00M
919.00M
384.00M
561.00M
Effective tax rate
25.96%
29.51%
26.12%
17.32%
Other operating expenses
-
-
-
-
Net income
1.31B
2.20B
1.09B
2.68B
Net profit margin
10.68%
18.01%
8.69%
23.30%
Earnings per share
1.46
1.63
1.26
1.58
Interest and investment income
139.00M
161.00M
148.00M
-
Interest expense
-485.00M
-482.00M
-432.00M
-
Net interest expenses
-346.00M
-321.00M
-284.00M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
5.12B
4.91B
4.54B
3.96B
Gain or loss from assets sale
-7.00M
-9.00M
-
-34.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer